Expert Insights on Highlights From ASH 2020 on Multiple Myeloma

In this episode, Dr. Shaji Kumar from the Mayo Clinic and Dr. Sagar Lonial from Emory University discuss highlights of the key data from ASH 2020 on the treatment of patients with multiple myeloma. Topics include:Newly diagnosed multiple myelomaRelapsed/refractory multiple myelomaAnti-BCMA therapy: CAR T-cellsAnti-BCMA therapy: bispecific antibodiesAnti-BCMA therapy: antibody–drug conjugatesNovel targeted agents for relapsed/refractory multiple myelomaPresenters:Shaji K. Kumar, MDMark and Judy Mullins Professor of Hematological MalignanciesChair, Myeloma Amyloidosis Dysproteinemia GroupConsultant, Division of HematologyMayo ClinicRochester, MinnesotaSagar Lonial, MDProfessor and ChairDepartment of Hematology and Medical OncologyChief Medical OfficerWinship Cancer Institute of Emory UniversityAtlanta, GeorgiaLink to the CCO website: http://bit.ly/30EqUn0

There are no comments yet.

Please log in to write the first comment.